Histogen Inc. Profile Avatar - Palmy Investing

Histogen Inc.

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clini…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Histogen Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Histogen Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Histogen Inc..

End of HSTO's Analysis
CIK: 1383701 CUSIP: 43358Y103 ISIN: US43358Y2028 LEI: - UEI: -
Secondary Listings
HSTO has no secondary listings inside our databases.